Laboratory of Viral Infectious Diseases (RIKEN) Does not recruit students for the academic year 2019

Professor Yoko AIDA
E-mail: aida{at}
Lab HP

Associate Professor Shin-nosuke TAKESHIMA
E-mail: takesima{at}


【Key Words】vaccine development,anti-viral drug development, bovine leukemia virus, influenza virus, human immunodeficiency virus

 Currently, infections account for about 30% of annual mortalities worldwide,and it is feared that the ratio may rise abruptly in the future. This is because new viral infections have recently emerged one after another. One representative of such infections is AIDS, which kills about three million people every year. As well as human immunodeficiency virus type I (HIV-I)is the etiologic agents of AIDS, human T cell leukemia virus type I (HTLV-I)induced adult T-cell leukemia (ATL) and bovine leukemia virus (BLV) induced enzootic bovine leukosis (EBL) constitute a unique subgroup within the retrovirus family
 The main subject of our laboratory is to understand the molecular mechanisms of AIDS induced by HIV-I and leukemogenesis induced by HTLV-I and BLV, and to develop new methods for prevention for these viral pathogenesis.
 In preparation for the coming threats from newlyemerging viruses,our laboratory focuses on the development of a new drug targeting a replication mechanism shared by many viruses.


The University of Tokyo
Graduate School of Frontier Sciences, The University of Tokyo

Page Top